American Psychiatric Association (2022). Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). 5th ed. Arlington, VA: American Psychiatric Publishing.
Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. (1989). Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWAAr). Br J Addict., 84(11): 1353-1357.
Skala K., Caputo F., Mirijello A., Vassallo G., Antonelli M., Ferrulli A., Walter H., Lesch O., Addolorato G. (2014). Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention. Expert Opin Pharmacother., 15(2): 245-257.
Leone M.A., Vigna-Taglianti F., Avanzi G., Brambilla R., Faggiano F. (2010). Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst Rev., (2), CD006266.
Caputo F., Vignoli T., Maremmani I., Bernardi M., Zoli G. (2009). Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review. Int J Environ Res Public Health, 6(6): 1917-1929.
Ministero della Salute (2021). Linee di indirizzo per il trattamento dei disturbi correlati al consumo di alcol. Roma: Ministero della Salute.
